Director Carolyn M. Burke bought 900 shares at $26.47 avg in 2 transactions (Feb 24-27); +39.1% increase to 3,200 shares amid cluster buying pattern
Director Carolyn M. Burke purchased 900 shares totaling $23,822.50 across 2 transactions on 2025-02-24 and 2025-02-27, expanding her holding from 2,300 shares to 3,200 shares (+39.1%). The purchases occurred at $26.50 and $26.45, with a blended average price of $26.47, roughly 0.48% below the current price of $26.99. Notably, this director's buying activity is part of a broader insider cluster pattern: 2 other insiders also purchased shares within the past 14 days at Finward Bancorp. While her 3 prior trades at this ticker (all buys in early February) remain outcome-unmeasurable at 90 days, the recent concentrated buying activity by multiple insiders may signal internal appetite at current valuation levels. The company trades at a P/E of 10.07 with a market cap of $116,429,974.81, positioning it as a smaller-cap name.
Director Carolyn M. Burke buys 1,000 shares of Finward Bancorp (FNWD) at $26.80 as part of cluster activity with 2 other insiders in 14 days.
Director Carolyn M. Burke purchased 1,000 shares at $26.80 on 2025-02-03, establishing an initial position in Finward Bancorp after holding zero shares previously. This purchase occurs within a 14-day cluster during which 2 other insiders also bought, suggesting coordinated board-level interest despite recent price weakness: the stock is currently $26.50, down 18.2% from its 52-week high of $32.40 and down 14.5% over the past 90 days. The company trades at a P/E of 9.89 with net income of $606,000.00 and a market cap of $114,316,203.50, characteristics consistent with a small-cap financial institution. Burke's cross-ticker transaction history shows only 2 prior buys across all holdings, limiting ability to assess her timing accuracy; her prior trades at FNWD are too recent to measure 90-day outcomes. The cluster pattern among multiple directors during a period of declining valuation warrants investor attention to whether material developments are driving coordinated accumulation or whether this reflects routine board investment practices.
Director Carolyn M. Burke purchases 500 FNWD shares at $26.85; 3-insider cluster buy amid -14.5% 90-day decline
Carolyn M. Burke, a director, purchased 500 shares at $26.85 on 2025-02-06, increasing her holdings from 1,000 to 1,500 shares (+50.0%). This transaction is part of a cluster pattern: 2 other insiders bought within the past 14 days, suggesting coordinated interest at this price level. However, the timing context is challenging—the stock has declined 14.5% over 90 days and is currently 18.2% below its 52-week high of $32.40, trading at $26.50. Burke's prior trades at FNWD (2 buys on 2025-02-07 and 2025-02-03) have no measurable outcomes yet. The company's fundamentals show a P/E of 9.89 with net income of $606,000.00 and a market cap of $114.3M, suggesting a relatively small-cap bank in a depressed state. The cluster buy pattern warrants attention to whether insiders see value, but the lack of price recovery and extended decline period raises questions about conviction timing.
Director Carolyn M. Burke purchases 800 FNWD shares at $26.50; cluster buy pattern with 2 other insiders in past 14 days
Carolyn M. Burke, Director, purchased 800 shares of Finward Bancorp at $26.50 on 2025-02-07, increasing her holdings from 1,500 to 2,300 shares. This transaction is noteworthy because it occurs as part of a cluster pattern: 2 other insiders also bought within the past 14 days, and Burke herself has conducted two additional open-market purchases at this ticker in the immediately preceding days (2025-02-06 and 2025-02-03, outcomes not yet measurable). The stock is currently trading at $26.50, down 18.2% from its 52-week high of $32.40 and down 14.5% over the past 90 days. The company shows a P/E of 9.89 with net income of $606,000.00, suggesting a low valuation multiple relative to earnings. The pattern of repeated insider accumulation at the same ticker warrants attention as a potential signal of insider assessment of value.